Author: Matthew Nelson|| Date Published: August 19, 2020
Ology Bioservices has won a one-year, $106.3M reserve production capacity contract for more than 186M doses of COVID-19 vaccines and other treatments to support the Trump administration's Operation Warp Speed.
Army Contracting Command received eight bids for the firm-fixed-price contract that seeks to address an urgent domestic requirement for aseptic fill and finish services amid the coronavirus pandemic, the Department of Defense said Tuesday.
The Alachua, Fla.-based biopharmaceutical company received $53.1M at the time of award and is expected to complete work by Aug. 10, 2021.
SentinelOne, a company specializing in artificial intelligence security, has promoted Barry Padgett to president and chief operating officer. The appointment takes effect…
Anduril Industries and Palantir Technologies are helping develop software for the potential $185 billion Golden Dome next-generation missile defense shield,…
Former CACI International executive Jeffrey Keen has been named senior vice president of federal civilian programs at defense and national security company Xcelerate Solutions.…
